0000000000321140

AUTHOR

Gaetano Ciancio

showing 4 related works from this author

Vascular complications following bladder drained, simultaneous pancreas-kidney transplantation: the University of Miami experience

2000

Vascular complications remain a significant nonimmunologic source of pancreas allograft loss. From February 1993 through January 1998, we performed 98 simultaneous pancreas-kidney transplantations (SPK) using pancreatic exocrine bladder drainage in patients with type 1 insulin-dependent diabetes mellitus and end-stage renal disease. They originally received quadruple immunosuppression, and since May 1997 triple immunosuppression protocol (tacrolimus, mycophenolate mofetil, and steroids). The patients' mean age was 37 years (range 24-53 years), including 50 women and 48 men with a mean follow-up of 42 months. The overall rate of vascular complications was 6% (5 patients). The vascular compli…

NephrologyAdultMalemedicine.medical_specialtyTime FactorsUrinary BladderArteriovenous fistulaHospitals UniversityPseudoaneurysmMesenteric VeinsPostoperative ComplicationsMesenteric Artery Superiormedicine.arteryInternal medicinemedicineHumansDiabetic NephropathiesSuperior mesenteric arteryVascular DiseasesSuperior mesenteric veinRetrospective StudiesVenous ThrombosisTransplantationbusiness.industryAnticoagulantsMiddle Agedmedicine.diseaseThrombosisKidney TransplantationSurgerymedicine.anatomical_structureDiabetes Mellitus Type 1Splenic veinFloridaKidney Failure ChronicDrug Therapy CombinationFemalePancreas TransplantationPancreasbusinessAneurysm FalseImmunosuppressive AgentsSpleenTransplant International
researchProduct

Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation

2000

Clinical trials using quadruple immunosuppression that include the combination of tacrolimus and mycophenolate mofetil have been shown to reduce the incidence of acute rejection episodes in simultaneous pancreas-kidney (SPK) transplantation. In an attempt to obtain a low rejection rate without antibody induction therapy, we undertook a prospective study of combined tacrolimus and mycophenolate mofetil and steroids as primary immunosuppression for SPK transplantation. In this study, we analyzed 17 patients who received low-dose intravenous tacrolimus as induction therapy. This was combined with oral tacrolimus, mycophenolate mofetil, and steroids as the primary immunosuppression regimen. The…

AdultGraft RejectionMaleNephrologymedicine.medical_specialtyBiopsymedicine.medical_treatmentUrinary Bladderchemical and pharmacologic phenomenaPancreas transplantationGastroenterologyTacrolimusMycophenolic acidInternal medicinemedicineHumansKidney transplantationTransplantationLeukopeniabusiness.industryImmunosuppressionMiddle AgedMycophenolic Acidmedicine.diseaseKidney TransplantationTacrolimusTransplantationsurgical procedures operativeDrug Therapy CombinationFemaleSteroidsPancreas Transplantationmedicine.symptombusinessmedicine.drugTransplant International
researchProduct

Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival

2016

Background Renal cell carcinoma forming a venous tumor thrombus (VTT) in the inferior vena cava (IVC) has a poor prognosis. Recent investigations have been focused on prognostic markers of survival. Thrombus consistency (TC) has been proposed to be of significant value but yet there are conflicting data. The aim of this study is to test the effect of IVC VTT consistency on cancer specific survival (CSS) in a multi-institutional cohort. Methods The records of 413 patients collected by the International Renal Cell Carcinoma–Venous Thrombus Consortium were retrospectively analyzed. All patients underwent radical nephrectomy and tumor thrombectomy. Kaplan–Meier estimate and Cox regression analy…

medicine.medical_specialtyProportional hazards modelbusiness.industrymedicine.medical_treatment030232 urology & nephrologyRetrospective cohort studyGeneral Medicinemedicine.diseaseInferior vena cavaNephrectomy03 medical and health sciences0302 clinical medicineOncologymedicine.veinRenal cell carcinoma030220 oncology & carcinogenesismedicineSurgeryRadiologyThrombusStage (cooking)businessSurvival analysisJournal of Surgical Oncology
researchProduct

ASSOCIATION OF AN ORGAN TRANSPLANT-BASED APPROACH WITH A DRAMATIC REDUCTION IN POSTOPERATIVE COMPLICATIONS FOLLOWING RADICAL NEPHRECTOMY AND TUMOR TH…

2019

Objectives: Our aim was to determine whether using an organ transplant-based(TB) approach reduces postoperative complications(PCs) following radical nephrectomy(RN) and tumor thrombectomy(TT) in renal cell carcinoma(RCC) patients with level II-IV thrombi. Methods: A total of 390(292 non-TB/98 TB) IRCC-VT Consortium patients who received no preoperative embolization/IVC filter were included. Stepwise linear/logistic regression analyses were performed to determine significant multivariable predictors of intraoperative estimated blood loss(IEBL), number blood transfusions received, and overall/major PC development within 30days following surgery. Propensity to receive the TB approach was contr…

MaleKidney DiseaseVena Cavamedicine.medical_treatment030232 urology & nephrologyLogistic regressionNephrectomyOrgan transplantation0302 clinical medicinePostoperative ComplicationsRenal cell carcinomaInferior vena cavaCancerThrombectomyGeneral MedicineMiddle AgedNephrectomyRenal cell carcinomaKidney NeoplasmsOncologymedicine.vein030220 oncology & carcinogenesisFemaleInferior vena cava; Postoperative complications; Renal cell carcinoma; Surgical technique; Tumor thrombus6.4 SurgeryInferiormedicine.medical_specialtyOncology and CarcinogenesisUrologyIvc filterVena Cava InferiorInferior vena cavaArticle03 medical and health sciencesPostoperative complicationsRare DiseasesBlood lossmedicineHumansBlood TransfusionOncology & CarcinogenesisCarcinoma Renal CellRetrospective Studiesbusiness.industryCarcinomaRenal CellEvaluation of treatments and therapeutic interventionsSurgical techniqueThrombosismedicine.diseasePostoperative complicationTumor thrombusPropensity score matchingSurgerybusinessFollow-Up Studies
researchProduct